Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04979728 · ClinicalTrials.gov registry record
HIV Outpatient Monitoring Evaluation Through Self-collection of Dried Blood Spots
A clinical trial of HIV Prevention and HIV Treatment, sponsored by University of Colorado, Denver.
- Recruiting
- Registry status
- 150
- Enrollment target
- 1
- Study location
NCT04979728: Recruiting study of HIV Prevention and HIV Treatment, sponsored by University of Colorado, Denver.
NCT04979728 is a study of HIV Prevention and HIV Treatment that is actively recruiting participants, run by University of Colorado, Denver. The registered enrollment target is 150 participants, below the 377-participant average among 32 other HIV Prevention trials with a reported enrollment target (60% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04979728, a study of HIV Prevention and HIV Treatment, is actively recruiting participants, sponsored by University of Colorado, Denver.
- RECRUITING
- Registry status
- 150 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this observational study is to establish an operational framework for home self-collections of blood samples to be used for antiviral drug concentration measurements. Participants will continue on their prescribed antiviral(s) for HIV treatment or prevention and followed for up to approximately 1 year. The investigators will compare drug concentrations of antivirals and relevant metabolites/anabolites in clinic-collected and self-collected blood samples.
Primary Outcome
Drug concentrations will be quantified and compared between clinic-collected and at home self-collected samples.
Conditions Studied
Interventions
- OTHER At Home Self-Collections
Study Locations (1)
Colorado
- University of Colorado Hospital (UCHealth) - Aurora
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2021-05-27 |
| Est. Completion | 2027-06-30 |
What NCT04979728 shows while recruiting
NCT04979728 is an observational study that tracks outcomes without assigning an intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap, below the 377-participant average among 32 other HIV Prevention trials with a reported enrollment target (60% lower).
The record links to 2 conditions, with HIV Prevention appearing as the primary indexed condition, and to 1 intervention - of which At Home Self-Collections is the first listed.
NCT04979728 reports a single indexed study location in Colorado.
Frequently Asked Questions
What is clinical trial NCT04979728 about?
NCT04979728 is a clinical study titled "HIV Outpatient Monitoring Evaluation Through Self-collection of Dried Blood Spots". The goal of this observational study is to establish an operational framework for home self-collections of blood samples to be used for antiviral drug concentration measurements. Participants will continue on their prescribed antiviral(s) for HIV treatment or prevention and followed for up to appro...
What is the current status of trial NCT04979728?
This trial is currently recruiting. The enrollment target is 150 participants. The study started on 2021-05-27. Estimated completion is 2027-06-30.
What conditions does trial NCT04979728 study?
This clinical trial studies the following conditions: HIV Prevention, HIV Treatment.
What interventions are being tested in trial NCT04979728?
The interventions under investigation include: At Home Self-Collections (OTHER).
Who is sponsoring clinical trial NCT04979728?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04979728 being conducted?
This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HIV Prevention
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04979728's enrollment target sits among peer trials
150 15th of 32 higher than 18 of 32 other HIV Prevention trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other HIV Prevention trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Using PrEP, Doing It for Ourselves
RECRUITING · NA
-
Client-Centered Care Coordination for Black Men Who Have Sex With Men
RECRUITING · NA
-
Behavioral Economic Intervention to Improve HIV Behaviors in Sexual Minority Individuals
RECRUITING · NA
-
Intervention to Enhance PrEP Persistence
RECRUITING · NA
-
Evaluation of Single Dosing With Two F/TAF Tablets Among Healthy Volunteers
RECRUITING · Phase 1
-
WePrEP: Developing a PrEP Shared Decision-making Tool for Transgender Women
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00412594 · 150 participants · Phase 2
Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia
- NCT01484730 · 150 participants
A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion
- NCT01985919 · 150 participants
Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples
- NCT02016248 · 150 participants · NA
SBRT Boost for Unfavorable Prostate Cancer'
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI